NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Update March 12, 2026

The benchmark indices declined by nearly 1 percent on March 12 due to rising oil prices amid Strait of Hormuz tensions. Market breadth was unfavorable for bulls as about 1,920 shares declined against 1,034 rising shares on the NSE. Geopolitical tensions are expected to continue affecting market sentiment.

Short-Term Trading Ideas

Ajanta Pharma (AJANTAPHARMA)

CMP: Rs 3,119.5

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Ajanta Pharma has broken out above the long-standing resistance zone of Rs 3,020–3,080, which has been in place since October 2024. The price now trades comfortably above all key EMAs, with upward-sloping averages. Momentum indicators remain in bullish territory, and trend indicators suggest the bullish move is likely to continue.

Strategy: Buy Target: Rs 3,381, Rs 3,450 Stop-Loss: Rs 2,945

HFCL (HFCL)

CMP: Rs 74.47

HFCL has formed a clear double-bottom bullish reversal pattern. Post-breakout, the price re-entered the pattern and formed a bullish tweezer bottom at the key support of Rs 64.5. Volume has increased over the past four consecutive sessions, and the stock trades above moving averages.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline

Strategy: Buy Target: Rs 79, Rs 83.3 Stop-Loss: Rs 69.5

Timken India (TIMKENINDIA)

CMP: Rs 3,486.5

Timken India broke out above a key resistance trendline on February 25. Since then, the price has hovered around the trendline and the 20-day EMA as support. Recent sessions show strong positive traction, with volume rising above average levels.

Strategy: Buy Target: Rs 3,685, Rs 3,800 Stop-Loss: Rs 3,200

Linde India (LINDEIND)

CMP: Rs 7,189.5

Linde India is displaying a strong bullish continuation setup on the daily chart. The stock has recently delivered a decisive breakout above the 200-day EMA, signaling a potential shift toward a sustained uptrend. Price action has formed an ascending triangle pattern, with a breakout above the consolidation resistance zone supported by expanding volumes.

Strategy: Buy Target: Rs 7,800 Stop-Loss: Rs 6,680

Jammu & Kashmir Bank (JKBK)

CMP: Rs 127.51

Jammu & Kashmir Bank has delivered a strong breakout from a prolonged six-month consolidation range. The stock confirmed the breakout after sustaining above the key resistance zone around Rs 110, which had repeatedly capped price advances in the past.

Strategy: Buy Target: Rs 137 Stop-Loss: Rs 120.5

Bharat Electronics (BEL)

CMP: Rs 453.55

BEL continues to exhibit a strong bullish trend on the daily timeframe. The stock has recently reclaimed its previous highs and is currently consolidating near its all-time high zone while taking support around the 20-day EMA.

Strategy: Buy Target: Rs 485 Stop-Loss: Rs 435

Supreme Industries (SUPREMEIND)

CMP: Rs 4,043.7

Supreme Industries is displaying a strong bullish reversal setup on the daily chart, marked by a well-defined trendline breakout. The price has consistently respected the 20-day EMA as a dynamic support during its uptrend phases, and the current pullback toward this level indicates healthy consolidation within a bullish structure.

Strategy: Buy Target: Not specified Stop-Loss: Not specified

Investor Takeaway

Consider buying Ajanta Pharma due to its strong technical indicators and breakout above resistance.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.